Patients With Diabetes Mellitus on Drug Treatment on the List or Already Undergoing Orthotopic Liver Transplantation

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Feb 6, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at patients with Type 2 diabetes who are either waiting for a liver transplant or have already received one. The goal is to gather important information about how well their diabetes is managed, their satisfaction with diabetes medications, and any complications they might face from diabetes or liver disease. Researchers will also evaluate the participants' survival over time. This study is important because it helps us understand how diabetes affects liver transplant patients and what can be done to improve their care.

To participate in this trial, individuals must be at least 18 years old, have Type 2 diabetes, and have been on the transplant waiting list for at least three months or have undergone a liver transplant for at least three months. Participants will need to give their written consent to join the study. The trial is currently recruiting, and it welcomes individuals of all genders. It's important to note that pregnant or breastfeeding women cannot participate. This study aims to improve the health and quality of life for those living with diabetes and facing liver transplant challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • type 2 diabetes mellitus
• • presence on the list for OLT for at least 3 months or have already been submitted to OLT for at least 3 months
• • age ≥ 18 years
• • signature of written informed consent to participate in the observational study, either by the participant or legal guardian
• Exclusion Criteria:
• • - Pregnancy or breastfeeding